HEALTH CARE FIRST PARTNERSHIP — All Prescriptions & Medications — Page 16
Practice Code: B87030 | LEEDS, LS26 9AA
Showing results 751-800 of 843
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 16 | 269 | £110 | -20.9% ▼ | |
| 16 | 160 | £227 | +144.2% ▲ | |
| Nadolol | 15 | 378 | £250 | +48.3% ▲ |
| Reboxetine | 15 | 1,120 | £337 | -2.6% ▼ |
| Tetracycline | 15 | 1,120 | £825 | +220.8% ▲ |
| Other selenium preparations | 15 | 400 | £199 | +58.9% ▲ |
| RtS 1.5 kcal/ml m/sk higher protein, higher energy (0913061) | 15 | 220.0K | £5.0K | +116.3% ▲ |
| Powder disc or non ACBS lactose free formula (0913352) | 15 | 32.0K | £638 | +92.6% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914011) | 15 | 406.0K | £6.3K | +29.8% ▲ |
| Antazoline | 15 | 150 | £48 | +237.6% ▲ |
| Lodoxamide trometamol | 15 | 150 | £74 | +145.9% ▲ |
| Mupirocin | 15 | 45 | £60 | +27.8% ▲ |
| 15 | 480 | £2.4K | +29.2% ▲ | |
| 15 | 1,440 | £2.8K | -8.1% ▼ | |
| 15 | 450 | £657 | +135.4% ▲ | |
| Chlorothiazide | 14 | 4,050 | £519 | +152.3% ▲ |
| Prazosin hydrochloride | 14 | 392 | £314 | -16.9% ▼ |
| Isosorbide dinitrate | 14 | 392 | £118 | -22.1% ▼ |
| Omega-3-acid ethyl esters | 14 | 784 | £379 | -33.8% ▼ |
| Lithium citrate | 14 | 9,900 | £368 | +55.7% ▲ |
| Oxycodone hydrochloride/naloxone hydrochloride | 14 | 770 | £582 | -19.3% ▼ |
| Hydrocortisone sodium phosphate | 14 | 46 | £94 | +235.5% ▲ |
| Testosterone esters | 14 | 21 | £49 | -5.1% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 14 | 4,980 | £77 | -38.9% ▼ |
| Tube feed 1 kcal/ml peptide based (0914041) | 14 | 392.0K | £7.4K | +57.5% ▲ |
| Ganciclovir | 14 | 70 | £266 | +250.6% ▲ |
| Mupirocin | 14 | 210 | £89 | +50.8% ▲ |
| Malathion | 14 | 2,400 | £221 | +119.2% ▲ |
| 14 | 159 | £66 | +18.1% ▲ | |
| 14 | 1,071 | £1.2K | +204.1% ▲ | |
| 14 | 300 | £136 | -32.8% ▼ | |
| 14 | 440 | £2.1K | +48.9% ▲ | |
| Torasemide | 13 | 364 | £124 | +15.8% ▲ |
| Pseudoephedrine hydrochloride | 13 | 700 | £163 | +149.6% ▲ |
| Loprazolam mesilate | 13 | 182 | £145 | -1.8% vs avg |
| Denosumab | 13 | 13 | £2.3K | -52.2% ▼ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 13 | 4,028 | £271 | +63.2% ▲ |
| Tube feed 2 kcal/ml with fibre (0914011) | 13 | 202.5K | £4.5K | +22.6% ▲ |
| Ketorolac trometamol | 13 | 65 | £39 | +40.1% ▲ |
| 13 | 32 | £360 | -0.6% vs avg | |
| 13 | 1,470 | £4.6K | +6.7% ▲ | |
| 13 | 1,170 | £2.0K | +23.7% ▲ | |
| Celiprolol hydrochloride | 12 | 336 | £210 | -9.3% ▼ |
| Flupentixol hydrochloride | 12 | 784 | £105 | -45.3% ▼ |
| Colistimethate sodium | 12 | 720 | £4.5K | +6.1% ▲ |
| Medroxyprogesterone acetate | 12 | 360 | £704 | +36.0% ▲ |
| Triptorelin | 12 | 12 | £2.2K | -43.1% ▼ |
| Potassium chloride | 12 | 240 | £26 | -35.8% ▼ |
| Tube feed 1 kcal/ml (0914021) | 12 | 407.5K | £7.7K | +55.0% ▲ |
| 12 | 302 | £98 | +0.7% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.